Mahir Karakas
Hamburg, Germany
Dr. Mahir Karakas is a 41-year-old specialist for cardiology, intensive care medicine, emergency medicine and genetic counseling at the University Medical Center Hamburg-Eppendorf in Germany. He is the designated “W3-Professoressor for translational research and innovative clinical trials” at the Hamburg University (Else Kroener-Fresenius-Foundation). His research ranges from issues related to the prevention of cardiovascular disease, biomarkers of cardiometabolic diseases to clinical pharmacology of cardiovascular compounds, and animal models of myocardial infarction. Furthermore, he is involved in multiple randomized multi-centre clinical trials evaluating the effects of new pharmacologic compounds in cardiometabolic diseases, infectious diseases and sepsis, and is the head of the steering committee of various multi-centre, randomized, double-blinded investigator-initiated trials in the field of acute coronary syndrome, atrial fibrillation, heart failure, cardiogenic shock, COVID-19, ARDS, and sepsis.
